首页 > 最新文献

Acta gastro-enterologica Belgica最新文献

英文 中文
Editorial. 社论
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.51821/86.3.12360
C Reenaers, H De Schepper
In this issue several important original papers as well as extensive reviews can be highlighted. The management of pelvic abscesses is usually challenging and the drainage is mandatory to avoid pelvis sepsis. Recently, minimally invasive techniques, including endoscopic ultrasound- guided transrectal drainage have been associated with a high success rates and good safety results (1). Peeters et all retrospectively analysed 17 patients with pelvic abscess and demonstrated a success rate of the technique of 100% defined by a resolution of the abscess. The full details of the technique are described in the original manuscript. In the hepatic section, since the picture of cirrhosis has changed in the last 2 decades with more metabolic dysfunction-associated steatotic liver diseases (2), Kaze et al aimed to assess whether the epidemiological and the clinical course of hepatocellular carcinoma had also changed over the last 25 years. By comparing two cohorts respectively before and after 2005 no major epidemiological changes were found except a higher rate of Alcohol-related HCC in the old cohort compared to the recent cohort. Metabolic dysfunction was similar with 10% in all groups. The review section includes three interesting.
{"title":"Editorial.","authors":"C Reenaers, H De Schepper","doi":"10.51821/86.3.12360","DOIUrl":"10.51821/86.3.12360","url":null,"abstract":"In this issue several important original papers as well as extensive reviews can be highlighted. The management of pelvic abscesses is usually challenging and the drainage is mandatory to avoid pelvis sepsis. Recently, minimally invasive techniques, including endoscopic ultrasound- guided transrectal drainage have been associated with a high success rates and good safety results (1). Peeters et all retrospectively analysed 17 patients with pelvic abscess and demonstrated a success rate of the technique of 100% defined by a resolution of the abscess. The full details of the technique are described in the original manuscript. In the hepatic section, since the picture of cirrhosis has changed in the last 2 decades with more metabolic dysfunction-associated steatotic liver diseases (2), Kaze et al aimed to assess whether the epidemiological and the clinical course of hepatocellular carcinoma had also changed over the last 25 years. By comparing two cohorts respectively before and after 2005 no major epidemiological changes were found except a higher rate of Alcohol-related HCC in the old cohort compared to the recent cohort. Metabolic dysfunction was similar with 10% in all groups. The review section includes three interesting.","PeriodicalId":7322,"journal":{"name":"Acta gastro-enterologica Belgica","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An unusual cause of portal hypertension. 门静脉高压的一个不寻常的原因。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.51821/86.3.11925
K Ferdinande, T Lamiroy, A Hoorens, X Verhelst, H Degroote, S Raevens, H Van Vlierberghe, A Geerts
A 66-year-old male with a medical history of coronary artery disease presented with nonspecific symptoms of anorexia, lethargy and an increase in abdominal girth. He was diagnosed 3 months ago with chronic liver disease of undetermined aetiology. He did not smoke and was a social drinker till 4 months ago. He was taking tests showed progressive cholestatic liver enzymes (total bilirubin 1,09 mg/dL, AST 130 U/L, ALT 129 U/L, GGT 517 U/L and ALP 641 U/L) and a severe hypoalbuminemia. Laboratory workup made a metabolic, autoimmune, and viral aetiology of the suspected cirrhosis less probable. Urinalysis showed a rapidly progressive proteinuria in the nephrotic range accompanied by the presence of serum spike of monoclonal lambda light Furosemide, Aldactone, Pantoprazole, Acetylcysteine and Atorvastatin. He had no personal or familial history of liver diseases. Physical examination revealed a tender but distended abdomen and large ascites was present. The laboratory chain protein on electrophoresis with immunofixation. Doppler echocardiography revealed a hypertrophic cardiomyopathy based on diffuse left and right ventricular hypertrophy with relative apical sparing. A diagnostic paracentesis was undertaken and the results were consistent with portal hypertension (SAAG 1,6 g/ dL). Considering the concomitant presence of hypertrophic cardiomyopathy, nephrotic syndrome and a presentation of portal hypertension of undetermined aetiology in presence of a monoclonal IgG lambda light chain spike, a transjugular liver biopsy (figure 1 and 2) was performed with HVPG measurement consistent with significant portal hypertension (15 mmHg).
{"title":"An unusual cause of portal hypertension.","authors":"K Ferdinande, T Lamiroy, A Hoorens, X Verhelst, H Degroote, S Raevens, H Van Vlierberghe, A Geerts","doi":"10.51821/86.3.11925","DOIUrl":"10.51821/86.3.11925","url":null,"abstract":"A 66-year-old male with a medical history of coronary artery disease presented with nonspecific symptoms of anorexia, lethargy and an increase in abdominal girth. He was diagnosed 3 months ago with chronic liver disease of undetermined aetiology. He did not smoke and was a social drinker till 4 months ago. He was taking tests showed progressive cholestatic liver enzymes (total bilirubin 1,09 mg/dL, AST 130 U/L, ALT 129 U/L, GGT 517 U/L and ALP 641 U/L) and a severe hypoalbuminemia. Laboratory workup made a metabolic, autoimmune, and viral aetiology of the suspected cirrhosis less probable. Urinalysis showed a rapidly progressive proteinuria in the nephrotic range accompanied by the presence of serum spike of monoclonal lambda light Furosemide, Aldactone, Pantoprazole, Acetylcysteine and Atorvastatin. He had no personal or familial history of liver diseases. Physical examination revealed a tender but distended abdomen and large ascites was present. The laboratory chain protein on electrophoresis with immunofixation. Doppler echocardiography revealed a hypertrophic cardiomyopathy based on diffuse left and right ventricular hypertrophy with relative apical sparing. A diagnostic paracentesis was undertaken and the results were consistent with portal hypertension (SAAG 1,6 g/ dL). Considering the concomitant presence of hypertrophic cardiomyopathy, nephrotic syndrome and a presentation of portal hypertension of undetermined aetiology in presence of a monoclonal IgG lambda light chain spike, a transjugular liver biopsy (figure 1 and 2) was performed with HVPG measurement consistent with significant portal hypertension (15 mmHg).","PeriodicalId":7322,"journal":{"name":"Acta gastro-enterologica Belgica","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EUS-guided transrectal drainage of pelvic abscesses: a retrospective analysis of 17 patients. EUS引导下经直肠引流治疗盆腔脓肿:17例患者的回顾性分析。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.51821/86.3.12029
H Peeters, M Simoens, J Lenz

Background: Pelvic abscess is a common complication of abdominal surgery or intestinal or gynecological diseases. Over the last decades, endoscopic ultrasound (EUS)-guided drainage has emerged as a minimally invasive alternative to percutaneous or surgical treatment of pelvic abscesses.

Aim: To evaluate safety and efficacy of EUS-guided transrectal pelvic abscess drainage in a single center.

Methods: From February 2017 to April 2023, all data on patients who were treated for pelvic abscesses by EUS-guided drainage in a single center, were retrospectively analyzed.

Results: A total of 17 patients were treated for pelvic abscesses by EUS-guided drainage. The procedure was technically successful and uneventful in all 17 patients (100%). Etiology of the abscess was postsurgical (n=5, 29%), secondary to medical illness (n=10, 59%) or gastrointestinal perforation (n=2, 12%). The abscess was multilocular in 5 patients (29%), the mean largest diameter was 76 mm (range 40-146 mm). Drainage was performed using 2 double pigtail stents, and in 1 patient an additional 10 Fr drainage catheter was deployed. Two patients (12%) required a second endoscopic intervention. Treatment success, defined by complete abscess resolution on follow-up CT scan along with symptom relief, was 100%. There was no need for surgical intervention. The median post-procedural hospital stay was 5 days. No recurrence was reported within a median time of follow-up of 39 months.

Conclusion: EUS-guided transrectal drainage of pelvic abscesses using double pigtail stents is safe and highly effective. This case series contributes to the cumulative evidence that, in expert hands, EUS-guided drainage should be considered as first-line approach for treatment of pelvic abscesses.

背景:盆腔脓肿是腹部手术或肠道或妇科疾病的常见并发症。在过去的几十年里,内镜超声(EUS)引导引流已成为经皮或手术治疗盆腔脓肿的一种微创替代方法。目的:评价EUS引导下单中心经直肠盆腔脓肿引流术的安全性和有效性。方法:回顾性分析2017年2月至2023年4月在一个中心接受EUS引导引流治疗盆腔脓肿患者的所有数据。结果:共有17例患者接受了EUS引导下的盆腔脓肿引流治疗。该手术在技术上是成功的,所有17名患者(100%)都安然无恙。脓肿的病因为术后(n=5,29%),继发于内科疾病(n=10,59%)或胃肠道穿孔(n=2,12%)。脓肿为多房型5例(29%),平均最大直径为76mm(范围40-146mm)。使用2个双尾纤支架进行引流,1名患者使用额外的10Fr引流导管。两名患者(12%)需要第二次内镜介入治疗。治疗成功率为100%,其定义为在后续CT扫描中脓肿完全消退以及症状缓解。没有必要进行手术干预。术后平均住院时间为5天。中位随访时间39个月内无复发报告。结论:EUS引导下经直肠双尾纤支架引流治疗盆腔脓肿安全有效。该病例系列有助于累积证据,即在专家手中,EUS引导引流应被视为治疗盆腔脓肿的一线方法。
{"title":"EUS-guided transrectal drainage of pelvic abscesses: a retrospective analysis of 17 patients.","authors":"H Peeters,&nbsp;M Simoens,&nbsp;J Lenz","doi":"10.51821/86.3.12029","DOIUrl":"10.51821/86.3.12029","url":null,"abstract":"<p><strong>Background: </strong>Pelvic abscess is a common complication of abdominal surgery or intestinal or gynecological diseases. Over the last decades, endoscopic ultrasound (EUS)-guided drainage has emerged as a minimally invasive alternative to percutaneous or surgical treatment of pelvic abscesses.</p><p><strong>Aim: </strong>To evaluate safety and efficacy of EUS-guided transrectal pelvic abscess drainage in a single center.</p><p><strong>Methods: </strong>From February 2017 to April 2023, all data on patients who were treated for pelvic abscesses by EUS-guided drainage in a single center, were retrospectively analyzed.</p><p><strong>Results: </strong>A total of 17 patients were treated for pelvic abscesses by EUS-guided drainage. The procedure was technically successful and uneventful in all 17 patients (100%). Etiology of the abscess was postsurgical (n=5, 29%), secondary to medical illness (n=10, 59%) or gastrointestinal perforation (n=2, 12%). The abscess was multilocular in 5 patients (29%), the mean largest diameter was 76 mm (range 40-146 mm). Drainage was performed using 2 double pigtail stents, and in 1 patient an additional 10 Fr drainage catheter was deployed. Two patients (12%) required a second endoscopic intervention. Treatment success, defined by complete abscess resolution on follow-up CT scan along with symptom relief, was 100%. There was no need for surgical intervention. The median post-procedural hospital stay was 5 days. No recurrence was reported within a median time of follow-up of 39 months.</p><p><strong>Conclusion: </strong>EUS-guided transrectal drainage of pelvic abscesses using double pigtail stents is safe and highly effective. This case series contributes to the cumulative evidence that, in expert hands, EUS-guided drainage should be considered as first-line approach for treatment of pelvic abscesses.</p>","PeriodicalId":7322,"journal":{"name":"Acta gastro-enterologica Belgica","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of recurrent Clostridioides difficile infections with faecal microbiota transplantation: peri-procedural methods in a consecutive case series. 粪便微生物群移植治疗复发性艰难梭菌感染:连续病例系列的围手术期方法。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.51821/86.3.11795
K Korpak, L Defourny, S Lali, M Delvallée, R Demeester, E Toussaint

Background: Faecal microbiota transplantation (FMT) has high efficacy against recurrent Clostridioides difficile infection (CDI). Despite the increasing use of this therapy, the delay between diagnosis and treatment is excessive. Furthermore, donor selection is an important and time-consuming process.

Methods: We reviewed patients who underwent FMT for recurrent CDI at the CHU Charleroi Hospital between 2015 and 2022. The general context, type of administration, adverse events, and donor selection were reported. FMT was conducted using gastroduodenoscopy, colonoscopy, and enema with either fresh or frozen material.

Results: Ten patients with multiple comorbidities were treated by FMT. Seven patients were cured after one procedure. One patient was successfully cured after a change to an unrelated donor, and preliminary efficacy was established.

Conclusions: FMT is an effective treatment that should be considered during the earlier phases of treatment. Stool donors should be thoroughly screened for infectious diseases and other criteria related to microbiota composition.

背景:粪便微生物群移植(FMT)对复发性艰难梭菌感染(CDI)具有很高的疗效。尽管这种疗法的使用越来越多,但诊断和治疗之间的延迟是过度的。此外,捐助者的选择是一个重要而耗时的过程。方法:我们回顾了2015年至2022年间在CHU Charleroi医院接受FMT治疗复发性CDI的患者。报告了一般情况、给药类型、不良事件和供体选择。FMT采用胃十二指肠镜、结肠镜和新鲜或冷冻材料灌肠进行。结果:10例合并多种疾病的患者均接受FMT治疗。7名患者在一次手术后治愈。一名患者在更换为无关供体后成功治愈,初步疗效已确定。结论:FMT是一种有效的治疗方法,应在治疗的早期阶段加以考虑。粪便捐献者应彻底筛查传染病和其他与微生物群组成有关的标准。
{"title":"Treatment of recurrent Clostridioides difficile infections with faecal microbiota transplantation: peri-procedural methods in a consecutive case series.","authors":"K Korpak,&nbsp;L Defourny,&nbsp;S Lali,&nbsp;M Delvallée,&nbsp;R Demeester,&nbsp;E Toussaint","doi":"10.51821/86.3.11795","DOIUrl":"10.51821/86.3.11795","url":null,"abstract":"<p><strong>Background: </strong>Faecal microbiota transplantation (FMT) has high efficacy against recurrent Clostridioides difficile infection (CDI). Despite the increasing use of this therapy, the delay between diagnosis and treatment is excessive. Furthermore, donor selection is an important and time-consuming process.</p><p><strong>Methods: </strong>We reviewed patients who underwent FMT for recurrent CDI at the CHU Charleroi Hospital between 2015 and 2022. The general context, type of administration, adverse events, and donor selection were reported. FMT was conducted using gastroduodenoscopy, colonoscopy, and enema with either fresh or frozen material.</p><p><strong>Results: </strong>Ten patients with multiple comorbidities were treated by FMT. Seven patients were cured after one procedure. One patient was successfully cured after a change to an unrelated donor, and preliminary efficacy was established.</p><p><strong>Conclusions: </strong>FMT is an effective treatment that should be considered during the earlier phases of treatment. Stool donors should be thoroughly screened for infectious diseases and other criteria related to microbiota composition.</p>","PeriodicalId":7322,"journal":{"name":"Acta gastro-enterologica Belgica","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
What do we know today about drug-induced microscopic colitis? A case of lymphocytic colitis on olmesartan. 我们今天对药物诱导的显微镜下结肠炎了解多少?奥美沙坦治疗淋巴细胞性结肠炎1例。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.51821/86.3.11361
A Djembissi Fotso, M Arvanitakis, M Salame, J Gallez, A Lakis

Microscopic colitis is part of the differential diagnosis of chronic watery diarrhea. Colonoscopy discloses a normal looking mucosa, therefore its diagnosis is based on histology of colonic biopsies. Two main phenotypes are distinguished: collagenous colitis and lymphocytic colitis. A third entity, incomplete microscopic colitis or unspecified microscopic colitis has been reported in the literature. It affects preferentially women over 60 years of age and its association with certain drugs is increasingly established. In case of suspected drug-induced microscopic colitis, identification of the responsible drug is a key to management. After discontinuation of the suspected drug, the gold standard of treatment is budesonide both for induction and for maintenance in case of clinical relapse, as is often the case after discontinuation. Therapy with immunomodulators, biologics, or surgery is reserved for refractory forms of microscopic colitis after multidisciplinary consultation. Through the clinical case of colitis on olmesartan, we will review the latest recommendations on drug-induced microscopic colitis.

显微镜下结肠炎是鉴别诊断慢性水样腹泻的一部分。结肠镜检查显示粘膜外观正常,因此其诊断是基于结肠活检的组织学。有两种主要表型:胶原性结肠炎和淋巴细胞性结肠炎。第三种实体,不完全性显微镜下结肠炎或未指明的显微镜下结肠炎已在文献中报道。它优先影响60岁以上的女性,而且它与某些药物的联系越来越牢固。在疑似药物诱导的显微镜下结肠炎的情况下,确定责任药物是管理的关键。停用可疑药物后,治疗的金标准是布地奈德,用于诱导和在临床复发的情况下维持,停药后通常也是如此。免疫调节剂、生物制剂或手术治疗保留用于多学科会诊后的难治性显微镜下结肠炎。通过奥美沙坦治疗结肠炎的临床案例,我们将回顾药物诱导显微镜下结肠炎的最新建议。
{"title":"What do we know today about drug-induced microscopic colitis? A case of lymphocytic colitis on olmesartan.","authors":"A Djembissi Fotso,&nbsp;M Arvanitakis,&nbsp;M Salame,&nbsp;J Gallez,&nbsp;A Lakis","doi":"10.51821/86.3.11361","DOIUrl":"10.51821/86.3.11361","url":null,"abstract":"<p><p>Microscopic colitis is part of the differential diagnosis of chronic watery diarrhea. Colonoscopy discloses a normal looking mucosa, therefore its diagnosis is based on histology of colonic biopsies. Two main phenotypes are distinguished: collagenous colitis and lymphocytic colitis. A third entity, incomplete microscopic colitis or unspecified microscopic colitis has been reported in the literature. It affects preferentially women over 60 years of age and its association with certain drugs is increasingly established. In case of suspected drug-induced microscopic colitis, identification of the responsible drug is a key to management. After discontinuation of the suspected drug, the gold standard of treatment is budesonide both for induction and for maintenance in case of clinical relapse, as is often the case after discontinuation. Therapy with immunomodulators, biologics, or surgery is reserved for refractory forms of microscopic colitis after multidisciplinary consultation. Through the clinical case of colitis on olmesartan, we will review the latest recommendations on drug-induced microscopic colitis.</p>","PeriodicalId":7322,"journal":{"name":"Acta gastro-enterologica Belgica","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tofacitinib, celiac disease and the elderly: mind the gut! 托法替尼、乳糜泻和老年人:注意肠道!
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.51821/86.3.12207
N Boutrid, H Rahmoune
To the Editor, We read with great attention the interesting case report by Lenfant et al. narrating the successful use of tofacitinib in a patient with microscopic colitis and celiac disease (1), and we would point some insights about this peculiar situation. In fact, tofacitinib depicts potential side effects, including a higher risk of malignancies, and the FDA has even issued a warning about this drug’s hazard (2). Actually, a randomized open-label trial published in the New England Journal of Medicine in 2021 found that patients with rheumatoid arthritis who took tofacitinib had a higher risk of developing cancer than those who took a tumor necrosis factor (TNF) inhibitor (3). Recently, two recent randmoized controlled trials from the ORAL Surveillance Trial and published in the Annals of the Rheumatic Diseases in 2023 also contributed to shed the light on this potential risk : that patients with rheumatoid arthritis aged > 50 with cardiovascular risk who took tofacitinib had a higher risk of developing any type of cancer than those who took a TNF inhibitor (4), and secondary stratification found that they were more likely to develop cancer if they were over the age of 65 years (5). Adding insult to injury, the maligancies are also driven by the two peculiar forms of celiac disease : seronegative and refractory celiac disease (RCD), and this risk is also increased in CD diagnosed at adulthood : particularly, elder patients are prone to present a RCD, and giving immune checkpoint therapy might increase this risk (6). In conclusion, RCD ought to be definetly ruled out before starting JAK inhibitor therapy, especially in aged population with seronegative celiac disease and microscopic colitis, two well-known conditions associated with RCD.
{"title":"Tofacitinib, celiac disease and the elderly: mind the gut!","authors":"N Boutrid,&nbsp;H Rahmoune","doi":"10.51821/86.3.12207","DOIUrl":"10.51821/86.3.12207","url":null,"abstract":"To the Editor, We read with great attention the interesting case report by Lenfant et al. narrating the successful use of tofacitinib in a patient with microscopic colitis and celiac disease (1), and we would point some insights about this peculiar situation. In fact, tofacitinib depicts potential side effects, including a higher risk of malignancies, and the FDA has even issued a warning about this drug’s hazard (2). Actually, a randomized open-label trial published in the New England Journal of Medicine in 2021 found that patients with rheumatoid arthritis who took tofacitinib had a higher risk of developing cancer than those who took a tumor necrosis factor (TNF) inhibitor (3). Recently, two recent randmoized controlled trials from the ORAL Surveillance Trial and published in the Annals of the Rheumatic Diseases in 2023 also contributed to shed the light on this potential risk : that patients with rheumatoid arthritis aged > 50 with cardiovascular risk who took tofacitinib had a higher risk of developing any type of cancer than those who took a TNF inhibitor (4), and secondary stratification found that they were more likely to develop cancer if they were over the age of 65 years (5). Adding insult to injury, the maligancies are also driven by the two peculiar forms of celiac disease : seronegative and refractory celiac disease (RCD), and this risk is also increased in CD diagnosed at adulthood : particularly, elder patients are prone to present a RCD, and giving immune checkpoint therapy might increase this risk (6). In conclusion, RCD ought to be definetly ruled out before starting JAK inhibitor therapy, especially in aged population with seronegative celiac disease and microscopic colitis, two well-known conditions associated with RCD.","PeriodicalId":7322,"journal":{"name":"Acta gastro-enterologica Belgica","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dumping syndrome after bariatric surgery: prevalence, pathophysiology and role in weight reduction - a systematic review. 减肥手术后的倾倒综合征:患病率、病理生理学和在减肥中的作用——一项系统综述。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.51821/86.3.11476
A D'hoedt, T Vanuytsel

Background: Dumping syndrome is a frequent and wellknown adverse event after bariatric surgery and covers a dynamic spectrum of early and late dumping. Accelerated gastric emptying is generally considered to be the cause of gastrointestinal and vasomotor complaints. However, there is much uncertainty regarding the exact pathophysiology of dumping. It has been speculated that the syndrome is a desired consequence of bariatric surgery and contributes to more efficient weight loss, but supporting data are scarce.

Methods: A systematic search was conducted in PubMed in July-August 2021. The prevalence of dumping after the most frequently performed bariatric procedures was analyzed, as well as underlying pathophysiology and its role in weight reduction.

Results: Roux-en-Y gastric bypass (RYGB) is associated with the highest postoperative prevalence of dumping. The fast transit induces neurohumoral changes which contribute to an imbalance between postprandial glucose and insulin levels, resulting in hypoglycemia which is the hallmark of late dumping. Early dumping can, when received in a positive way, become a tool to maintain a strict dietary pattern, but no significant relationship to the degree of weight loss has been shown. However, late dumping is detrimental and promotes overall higher caloric intake.

Conclusion: Dumping syndrome is common after bariatric surgery, especially after RYGB. The pathophysiology is complex and ambiguous. Currently available data do not support dumping as a necessary condition to induce weight loss after bariatric surgery.

背景:倾倒综合征是减肥手术后常见且众所周知的不良事件,涵盖了早期和晚期倾倒的动态范围。胃排空加速通常被认为是胃肠道和血管舒缩性疾病的原因。然而,倾倒的确切病理生理学还有很多不确定性。据推测,该综合征是减肥手术的理想结果,有助于更有效地减肥,但支持数据很少。方法:于2021年7-8月在PubMed进行系统检索。分析了最常见的减肥手术后倾倒的发生率,以及潜在的病理生理学及其在减肥中的作用。结果:Roux-en-Y胃分流术(RYGB)与术后倾倒发生率最高有关。快速转运诱导神经体液变化,导致餐后血糖和胰岛素水平失衡,导致低血糖,这是晚倾倒的标志。如果以积极的方式接受,早期倾倒可以成为保持严格饮食模式的工具,但与减肥程度没有显著关系。然而,延迟倾倒是有害的,并促进整体更高的热量摄入。结论:Dumping综合征常见于减肥手术后,尤其是RYGB手术后。病理生理学是复杂和模糊的。目前可用的数据不支持倾倒作为减肥手术后诱导体重减轻的必要条件。
{"title":"Dumping syndrome after bariatric surgery: prevalence, pathophysiology and role in weight reduction - a systematic review.","authors":"A D'hoedt,&nbsp;T Vanuytsel","doi":"10.51821/86.3.11476","DOIUrl":"10.51821/86.3.11476","url":null,"abstract":"<p><strong>Background: </strong>Dumping syndrome is a frequent and wellknown adverse event after bariatric surgery and covers a dynamic spectrum of early and late dumping. Accelerated gastric emptying is generally considered to be the cause of gastrointestinal and vasomotor complaints. However, there is much uncertainty regarding the exact pathophysiology of dumping. It has been speculated that the syndrome is a desired consequence of bariatric surgery and contributes to more efficient weight loss, but supporting data are scarce.</p><p><strong>Methods: </strong>A systematic search was conducted in PubMed in July-August 2021. The prevalence of dumping after the most frequently performed bariatric procedures was analyzed, as well as underlying pathophysiology and its role in weight reduction.</p><p><strong>Results: </strong>Roux-en-Y gastric bypass (RYGB) is associated with the highest postoperative prevalence of dumping. The fast transit induces neurohumoral changes which contribute to an imbalance between postprandial glucose and insulin levels, resulting in hypoglycemia which is the hallmark of late dumping. Early dumping can, when received in a positive way, become a tool to maintain a strict dietary pattern, but no significant relationship to the degree of weight loss has been shown. However, late dumping is detrimental and promotes overall higher caloric intake.</p><p><strong>Conclusion: </strong>Dumping syndrome is common after bariatric surgery, especially after RYGB. The pathophysiology is complex and ambiguous. Currently available data do not support dumping as a necessary condition to induce weight loss after bariatric surgery.</p>","PeriodicalId":7322,"journal":{"name":"Acta gastro-enterologica Belgica","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A remarkable presentation of a massive Budd-Chiari syndrome. 一个巨大的布-加综合征的显著表现。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.51821/86.3.11994
K Ferdinande, H Degroote, A Geerts, H Van Vlierberghe, X Verhelst, S Raevens
A 59-year-old female presented to the emergency department with malaise, significant weight loss, abdominal discomfort, dyspnoea and severely swollen peripheral extremities. She had a past medical history of sickle cell anaemia, a latent tuberculosis infection and a chronic hepatitis B that was treated with PEG-interferon alpha-2 in 2008. Since 2018, she was lost to follow-up. The patient was critically ill, sarcopenic and lethargic. Clinical examination revealed icteric sclerae and a markedly distended and diffusely tender abdomen and peripheral oedemas. Her vital signs included a blood pressure of 105/64 mmHg, tachycardia of 130 bpm, hypothermia of 35.6°C and a SpO2 of 100% in ambient air. Laboratory workup demonstrated a total bilirubin of 12.9 mg/dL, AST 500 U/L, ALT 218 U/L, ALP 178 U/L and GGT 126 U/L, a thrombocytopenia of 34 x10E3/ μL, 16,01 x10E3/μL leukocytes, a CRP of 94.8 mg/L and a lactate of 10,12 mmol/L. The serum creatinine was 1.04 mg/dL, eGFR 54.1 ml/min. The INR was 2.77 and there was a severe hypoalbuminemia (22 g/L). D-dimers were >20 000 ng/ml. The patient presented also with spontaneous hypoglycaemia. A multiphasic contrast-enhanced thoracic and abdominal computed tomography (CT) was performed (figure 1). Given the results of the CT, a 2D echocardiogram was urgently requested (figure 2).
{"title":"A remarkable presentation of a massive Budd-Chiari syndrome.","authors":"K Ferdinande, H Degroote, A Geerts, H Van Vlierberghe, X Verhelst, S Raevens","doi":"10.51821/86.3.11994","DOIUrl":"10.51821/86.3.11994","url":null,"abstract":"A 59-year-old female presented to the emergency department with malaise, significant weight loss, abdominal discomfort, dyspnoea and severely swollen peripheral extremities. She had a past medical history of sickle cell anaemia, a latent tuberculosis infection and a chronic hepatitis B that was treated with PEG-interferon alpha-2 in 2008. Since 2018, she was lost to follow-up. The patient was critically ill, sarcopenic and lethargic. Clinical examination revealed icteric sclerae and a markedly distended and diffusely tender abdomen and peripheral oedemas. Her vital signs included a blood pressure of 105/64 mmHg, tachycardia of 130 bpm, hypothermia of 35.6°C and a SpO2 of 100% in ambient air. Laboratory workup demonstrated a total bilirubin of 12.9 mg/dL, AST 500 U/L, ALT 218 U/L, ALP 178 U/L and GGT 126 U/L, a thrombocytopenia of 34 x10E3/ μL, 16,01 x10E3/μL leukocytes, a CRP of 94.8 mg/L and a lactate of 10,12 mmol/L. The serum creatinine was 1.04 mg/dL, eGFR 54.1 ml/min. The INR was 2.77 and there was a severe hypoalbuminemia (22 g/L). D-dimers were >20 000 ng/ml. The patient presented also with spontaneous hypoglycaemia. A multiphasic contrast-enhanced thoracic and abdominal computed tomography (CT) was performed (figure 1). Given the results of the CT, a 2D echocardiogram was urgently requested (figure 2).","PeriodicalId":7322,"journal":{"name":"Acta gastro-enterologica Belgica","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective analysis of the histology of resected polyps and colonoscopy quality parameters in Belgium. 回顾性分析比利时切除息肉的组织学和结肠镜检查质量参数。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.51821/86.2.10880
E Macken, S Van Dongen, G Van Hal

Background and aims: adenoma detection rate is a well known quality parameter for colonoscopy. However recently other quality parameters have emerged. We wanted to evaluate the histology of the resected polyps, different quality indicators of colonoscopy and post colonoscopy colorectal cancer (PCCRC) in Belgium and analyzed data about colonoscopies performed between 2008-2015.

Methods: Reimbursement data on colorectal related medical procedures from the Intermutualistic Agency were linked with data on clinical and pathological staging of colorectal cancer and with histologic data of resected polyps available at the Belgian Cancer Registry over a period covering 8 years (2008-2015).

Results: 298,246 polyps were resected in 294,923 colonoscopies, of which 275,182 were adenomas (92 %) and 13,616 were SSLs (4%). There was a significant but small correlation between the different quality parameters and PCCRC. Post colonoscopy colorectal cancer rate after 3 years was 7.29 %. There were marked geographic differences in Belgium concerning adenoma detection rate, sessile adenoma detection rate and post colonoscopy colorectal cancer.

Conclusion: Most resected polyps were adenomas, only a small percentage involved sessile serrated lesions. There was a significant correlation between adenoma detection rate and other quality parameters, and a small but significant correlation between PCCRC and the different quality parameters. The lowest post colonoscopy colorectal cancer rate was reached with an ADR of 31.4 % and a SSL-DR of 1.2 %.

背景与目的:腺瘤检出率是结肠镜检查的一个重要质量指标。然而,最近出现了其他质量参数。我们想要评估比利时切除息肉的组织学,结肠镜检查和结肠镜检查后结直肠癌(PCCRC)的不同质量指标,并分析2008-2015年结肠镜检查的数据。方法:将Intermutualistic Agency提供的结直肠癌相关医疗程序的报销数据与比利时癌症登记处提供的结直肠癌临床和病理分期数据以及切除息肉的组织学数据相关联,时间跨度为8年(2008-2015年)。结果:294,923例结肠镜检查共切除息肉298,246例,其中腺瘤275,182例(92%),ssl16例(4%)。不同质量参数与PCCRC之间存在显著但较小的相关性。结肠镜检查后3年结直肠癌发生率为7.29%。比利时在腺瘤检出率、无底腺瘤检出率和结肠镜后结直肠癌方面存在显著的地理差异。结论:大部分切除的息肉为腺瘤,只有一小部分为无根的锯齿状病变。腺瘤检出率与其他质量参数相关性显著,PCCRC与不同质量参数相关性虽小但显著。结肠镜检查后结直肠癌发生率最低,ADR为31.4%,SSL-DR为1.2%。
{"title":"A retrospective analysis of the histology of resected polyps and colonoscopy quality parameters in Belgium.","authors":"E Macken,&nbsp;S Van Dongen,&nbsp;G Van Hal","doi":"10.51821/86.2.10880","DOIUrl":"https://doi.org/10.51821/86.2.10880","url":null,"abstract":"<p><strong>Background and aims: </strong>adenoma detection rate is a well known quality parameter for colonoscopy. However recently other quality parameters have emerged. We wanted to evaluate the histology of the resected polyps, different quality indicators of colonoscopy and post colonoscopy colorectal cancer (PCCRC) in Belgium and analyzed data about colonoscopies performed between 2008-2015.</p><p><strong>Methods: </strong>Reimbursement data on colorectal related medical procedures from the Intermutualistic Agency were linked with data on clinical and pathological staging of colorectal cancer and with histologic data of resected polyps available at the Belgian Cancer Registry over a period covering 8 years (2008-2015).</p><p><strong>Results: </strong>298,246 polyps were resected in 294,923 colonoscopies, of which 275,182 were adenomas (92 %) and 13,616 were SSLs (4%). There was a significant but small correlation between the different quality parameters and PCCRC. Post colonoscopy colorectal cancer rate after 3 years was 7.29 %. There were marked geographic differences in Belgium concerning adenoma detection rate, sessile adenoma detection rate and post colonoscopy colorectal cancer.</p><p><strong>Conclusion: </strong>Most resected polyps were adenomas, only a small percentage involved sessile serrated lesions. There was a significant correlation between adenoma detection rate and other quality parameters, and a small but significant correlation between PCCRC and the different quality parameters. The lowest post colonoscopy colorectal cancer rate was reached with an ADR of 31.4 % and a SSL-DR of 1.2 %.</p>","PeriodicalId":7322,"journal":{"name":"Acta gastro-enterologica Belgica","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10188528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Irritable bowel syndrome-like symptoms before and after bariatric surgery and association with short-chain fermentable carbohydrates consumption: an observational prospective study. 减肥手术前后肠易激综合征样症状与短链可发酵碳水化合物消耗的关系:一项观察性前瞻性研究
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2023-04-01 DOI: 10.51821/86.2.11530
P Van Ouytsel, H Piessevaux, A Szalai, P Loi, H Louis
Background and aims Irritable Bowel Syndrome (IBS)-like symptoms are frequent following bariatric surgery. This study aims to evaluate the frequency of IBS symptoms severity before and after bariatric surgery and their association with short-chain fermentable carbohydrates (FODMAPs) consumption. Patients and methods IBS symptoms severity in a cohort of obese patients was evaluated prospectively before, 6 and 12 months after bariatric surgery by validated questionnaires and tools (Irritable Bowel Syndrome Severity Scoring System (IBS SSS), Bristol Stool Scale (BSS), Quality of Life Short- Form-12 (SF-12), Hospital Anxiety and Depression scale (HAD)). FODMAPs consumption and its association with IBS symptom severity was evaluated by using a food frequency questionnaire focused on high-FODMAPs food consumption. Results Fifty-one patients were included (41 female; mean age 41 years (SD: 12)), 84% received a sleeve gastrectomy, and 16% a Roux-en-Y gastric bypass. Symptoms compatible with IBS were observed in 43% of patients before surgery, in 58% of patients at 6 months and 33% at 12 months (NS, p-value=0,197 and 0,414). In a multivariate model, a significant association was found between the IBS SSS score and lactose consumption at 6 months (β = + 58, 1; p = 0.03), and with polyols consumption at 12 months (β = + 112,6; p = 0.01). Conclusions Mild to moderate IBS symptoms are frequent in obese patients before bariatric surgery. A significant association between lactose and polyols consumption and IBS SSS score was observed after bariatric surgery, suggesting a potential link between the severity of IBS symptoms and some specific FODMAPs consumption.
背景和目的:肠易激综合征(IBS)样症状在减肥手术后很常见。本研究旨在评估减肥手术前后IBS症状严重程度的频率及其与短链可发酵碳水化合物(FODMAPs)摄入的关系。患者和方法:通过经验证的问卷和工具(肠易激综合征严重程度评分系统(IBS SSS)、布里斯托尔大便量表(BSS)、短期生活质量12(SF-12)、医院焦虑和抑郁量表(HAD)),在减肥手术前、手术后6个月和12个月前瞻性评估肥胖患者队列中的IBS症状严重程度。FODMAPs的摄入及其与IBS症状严重程度的关系通过使用关注高FODMAPs食物摄入的食物频率问卷进行评估。结果:51名患者(41名女性;平均年龄41岁(SD:12)),84%接受袖状胃切除术,16%接受Roux-en-Y胃旁路术。43%的患者在手术前、58%的患者在6个月时和33%的患者在12个月时观察到与IBS兼容的症状(NS,p值分别为0197和0414)。在一个多变量模型中,发现IBS SSS评分与6个月时的乳糖消耗量(β=+58,1;p=0.03)和12个月时多元醇消耗量(α=+112,6;p=0.01)之间存在显著相关性。结论:肥胖患者在减肥手术前经常出现轻度至中度IBS症状。减肥手术后观察到乳糖和多元醇的摄入与IBS SSS评分之间存在显著关联,这表明IBS症状的严重程度与某些特定FODMAP的摄入之间存在潜在联系。
{"title":"Irritable bowel syndrome-like symptoms before and after bariatric surgery and association with short-chain fermentable carbohydrates consumption: an observational prospective study.","authors":"P Van Ouytsel,&nbsp;H Piessevaux,&nbsp;A Szalai,&nbsp;P Loi,&nbsp;H Louis","doi":"10.51821/86.2.11530","DOIUrl":"10.51821/86.2.11530","url":null,"abstract":"Background and aims Irritable Bowel Syndrome (IBS)-like symptoms are frequent following bariatric surgery. This study aims to evaluate the frequency of IBS symptoms severity before and after bariatric surgery and their association with short-chain fermentable carbohydrates (FODMAPs) consumption. Patients and methods IBS symptoms severity in a cohort of obese patients was evaluated prospectively before, 6 and 12 months after bariatric surgery by validated questionnaires and tools (Irritable Bowel Syndrome Severity Scoring System (IBS SSS), Bristol Stool Scale (BSS), Quality of Life Short- Form-12 (SF-12), Hospital Anxiety and Depression scale (HAD)). FODMAPs consumption and its association with IBS symptom severity was evaluated by using a food frequency questionnaire focused on high-FODMAPs food consumption. Results Fifty-one patients were included (41 female; mean age 41 years (SD: 12)), 84% received a sleeve gastrectomy, and 16% a Roux-en-Y gastric bypass. Symptoms compatible with IBS were observed in 43% of patients before surgery, in 58% of patients at 6 months and 33% at 12 months (NS, p-value=0,197 and 0,414). In a multivariate model, a significant association was found between the IBS SSS score and lactose consumption at 6 months (β = + 58, 1; p = 0.03), and with polyols consumption at 12 months (β = + 112,6; p = 0.01). Conclusions Mild to moderate IBS symptoms are frequent in obese patients before bariatric surgery. A significant association between lactose and polyols consumption and IBS SSS score was observed after bariatric surgery, suggesting a potential link between the severity of IBS symptoms and some specific FODMAPs consumption.","PeriodicalId":7322,"journal":{"name":"Acta gastro-enterologica Belgica","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9867290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Acta gastro-enterologica Belgica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1